HomeTagsHospitality

hospitality

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...
spot_img
SGX-LISTED COMPANIES

Katrina Faces Debt & Insolvency In Q1 FY2026 – Is The End Near?

A Tale of Two Segments and one Liquidity Tightrope For many Singaporeans, Katrina Group is...
SGX-LISTED COMPANIES

The 77% Profit Surge At Frasers Property Everyone Missed In 1H FY2026

4 Surprising Takeaways from Frasers Property’s 1H FY2026 Results The global real estate market is...
SGX-LISTED COMPANIES

Shangri-La Asia’s New Secret Brand Is Changing Luxury Travel Forever – FY2025

https://open.spotify.com/episode/47qSjuUFLJE9weFQMF1MbL?si=7156e1bb681a4c90 5 Surprising Shifts Redefining the Future of Luxury at Shangri-La The global travel industry is...
SGX-LISTED COMPANIES

How Koh Brothers Engineered An $18.6 Million Turnaround In FY2025

https://open.spotify.com/episode/0MR3rCI8pluQ2MExvdb3st?si=84a1d2c0be0e4fca A Tale of Two Financial Years In the unforgiving arena of Singapore’s built environment, a...
Financial Services

India’s Hospitality Sector: A Bright Spot for Growth

Mark Matthews from Julius Baer sees the hospitality sector as a bright spot. It...

Latest articles

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...
Pharmaceutical

AstraZeneca expands diagnostics and AI to tackle late-stage cancer deaths

AstraZeneca is sharpening its long-term AstraZeneca cancer strategy with a combination of heavy research...
Pharmaceutical

AstraZeneca deploys AI to cut drug timelines by 30% and boost survival

AstraZeneca is stepping up its investment in AI drug discovery to shorten treatment timelines...